We aimed to explore the role of allele A/G single nucleotide polymorphism (SNP) of gene Interleukin 10 (IL-10) promoter-1082 in the susceptibility to gastric cancer through a systematic review and meta-analysis. Each initially included article was scored for quality appraisal. Desirable data were extracted and registered into databases. Twenty studies were ultimately eligible for the meta-analysis of IL-10-1082 A/G SNP. We adopted the most probably appropriate genetic model (dominant model), with the combined group of GG-plus-GA genotypes compared with the AA genotype. Potential sources of heterogeneity were sought out via subgroup analyses and sensitivity analyses, and publication biases were estimated. Between IL-10-1082 GG-plus-GA genotypes with the risk of developing gastric cancer, statistically significant association could be noted with overall gastric cancer, being mainly in Asian subgroup, large sample subgroup, high quality subgroup, intestinal-type subgroup, cardia-type subgroup, and some genotyping method subgroups. Our meta-analysis indicates that IL-10-1082 GG-plus-GA genotypes are associated with the overall risk of developing gastric cancer and seem to be more susceptible to overall gastric cancer in Asian populations. IL-10-1082 GG-plus-GA genotypes are more associated with the pathologically intestinal-type gastric cancer or anatomically cardia-type gastric cancer.
Get full access to this article
View all access options for this article.
References
1.
Alpízar-AlpízarW., Pérez-PérezG.I., UneC., CuencaP., SierraR.2005. Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica. Clin Exp Med, 5:169–176.
2.
BaiX.L., SunL.P., LiuJ., ChenW., ZhangY., YuanY.2008. Correlation of interleukin-1 0-1 082G/a single nucleotide polymorphism to the risk of gastric cancer in North China. A case-control study. Chinese J Cancer, 27:35–40.
3.
CamargoM.C., MeraR., CorreaP., PeekR.M.Jr., FonthamE.T., GoodmanK.J., PiazueloM.B., SicinschiL., ZabaletaJ., SchneiderB.G.2006. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 15:1674–1687.
4.
CrusiusJ.B., CanzianF., CapelláG., PeñaA.S., PeraG., SalaN., AgudoA., RicoF., Del GiudiceG., PalliD., PlebaniM., BoeingH., Bueno-de-MesquitaH.B., CarneiroF., PalaV., SaveV.E., VineisP., TuminoR., PanicoS., BerglundG., ManjerJ., StenlingR., HallmansG., MartínezC., DorronsoroM., BarricarteA., NavarroC., QuirósJ.R., AllenN., KeyT.J., BinghanS., CaldasC., LinseisenJ., KaaksR., OvervadK., TjønnelandA., BüchnerF.C., PeetersP.H., NumansM.E., Clavel-ChapelonF., TrichopoulouA., LundE., JenabM., RinaldiS., FerrariP., RiboliE., GonzálezC.A.2008. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST)Ann Oncol, 19:1894–1902.
5.
CuiY., XueH., LinB., NiP., FangJ.Y.2011. A meta-analysis of CDH1 C-160A genetic polymorphism and gastric cancer risk. DNA Cell Biol, 30:937–945.
6.
De VitaF., OrdituraM., GaliziaG., RomanoC., InfusinoS., AuriemmaA., LietoE., CatalanoG.1999. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer, 86:1936–1943.
7.
DengW., HeL., PengX.2008. The relationship among IL-10 gene polymorphisms, H elicobacter pylori and noncardia gastric cancer development in Fujian province. Chin J Gastroenterol Hepatol, 17:212–214.
8.
El-OmarE.M., RabkinC.S., GammonM.D., VaughanT.L., RischH.A., SchoenbergJ.B., StanfordJ.L., MayneS.T., GoedertJ., BlotW.J., FraumeniJ.F.Jr., ChowW.H.2003. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology, 124:1193–1201.
9.
García-GonzálezM.A., LanasA., QuinteroE., NicolásD., Parra-BlancoA., StrunkM., BenitoR., Angel SimónM., SantolariaS., SopeñaF., PiazueloE., JiménezP., PascualC., MasE., IrúnP., EspinelJ., CampoR., ManzanoM., GeijoF., PelliséM., González-HuixF., NietoM., EspinósJ., TitóL., BujandaL., ZaballaM. Spanish Gastroenterological Association AEG. 2007. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am J Gastroenterol, 102:1878–1892.
10.
GuoW., WangN., WangY.M., LiY., WenD.G., ChenZ.F., HeY.T., ZhangJ.H.2005. Interleukin-10-1082 promoter polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high-incidence region of north China. World J Gastroenterol, 11:858–862.
11.
HeidlG., LanghansP., MellinW., BunteH., GrundmannE.1993. Adeno-carcinomas of esophagus and cardia in comparison with gastric carcinoma. J Cancer Res Clin Oncol, 120:95–99.
12.
HwangI.R., KodamaT., KikuchiS., SakaiK., PetersonL.E., GrahamD.Y., YamaokaY.2002. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology, 123:1793–1803.
13.
KamangarF., AbnetC.C., HutchinsonA.A., NewschafferC.J., HelzlsouerK., ShugartY.Y., PietinenP., DawseyS.M., AlbanesD., VirtamoJ., TaylorP.R.2006. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland)Cancer Causes Control, 17:117–125.
14.
KangJ.M., KimN., LeeD.H., ParkJ.H., LeeM.K., KimJ.S., JungH.C., SongI.S.2009. The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea. J Clin Gastroenterol, 43:420–428.
15.
KimM.A., LeeH.S., YangH.K., KimW.H.2005. Clinicopathologic and protein expression differences betweencardia carcinoma and noncardia carcinoma of the stomach. Cancer, 103:1439–1446.
16.
KoK.P., ParkS.K., ChoL.Y., GwackJ., YangJ.J., ShinA., KimC.S., KimY., KangD., ChangS.H., ShinH.R., YooK.Y.2009. Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk. J Nutr, 139:1008–1012.
17.
LeeJ.Y., KimH.Y., KimK.H., KimS.M., JangM.K., ParkJ.Y., LeeJ.H., KimJ.H., YooJ.Y.2005. Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett, 225:207–214.
18.
LiuJ., SongB., WangJ.L., LiZ.J., LiW.H., WangZ.H.2011. Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. World J Gastroenterol, 17:1362–1367.
19.
LuW., PanK., ZhangL., LinD., MiaoX., YouW.2005. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis, 26:631–636.
20.
McCarronS.L., EdwardsS., EvansP.R., GibbsR., DearnaleyD.P., DoweA., SouthgateC., EastonD.F., EelesR.A., HowellW.M.2002. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res, 62:3369–3372.
21.
MocellinS., MarincolaF.M., YoungH.A.2005. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol, 78:1043–1051.
22.
MorganD.R., DominguezR.L., KekuT.O., HeidtP.E., MartinC.F., GalankoJ.A., OmofoyeO.A., SandlerR.S.2006. Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. Clin Gastroenterol Hepatol, 4:1103–1111.
23.
ParkinD.M., BrayF., FerlayJ., PisaniP.2005. Global cancer statistics, 2002. CA Cancer J Clin, 55:74–108.
24.
SaitoH., FukumotoY., OsakiT., FukudaK., TatebeS., TsujitaniS., IkeguchiM.2006. Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg, 30:1864–1869.
25.
SavageS.A., AbnetC.C., HaqueK., MarkS.D., QiaoY.L., DongZ.W., DawseyS.M., TaylorP.R., ChanockS.J.2004. Polymorphisms in interleukin −2, −6, and −10 are not associated with gastric cardia or esophageal cancer in a high-risk chinese population. Cancer Epidemiol Biomarkers Prev, 13:1547–1549.
26.
SeifartC., PlagensA., DempfleA., ClostermannU., VogelmeierC., von WichertP., SeifartU.2005. TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis Markers, 21:157–65.
27.
SuerbaumS., MichettiP.2002. Helicobacter pylori infection. N Engl J Med, 347:1175–1186.
28.
SugimotoM., FurutaT., ShiraiN., NakamuraA., KajimuraM., SugimuraH., HishidaA.2007. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol, 22:1443–1449.
29.
ThakkinstianA, McEvoyM., MinelliC., GibsonP., HancoxB., DuffyD., ThompsonJ., HallI., KaufmanJ., LeungT.F., HelmsP.J., HakonarsonH., HalpiE., NavonR., AttiaJ.2005a. Systematic review and metaanalysis of the association between{h}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol, 162:201–211.
30.
ThakkinstianA., McElduffP., D'EsteC., DuffyD., AttiaJ.2005b. A method for meta-analysis of molecular association studies. Stat Med, 24:1291–1306.
31.
TurnerD.M., WilliamsD.M., SankaranD., LazarusM., SinnottP.J., HutchinsonI.V.1997. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet, 24:1–8.
WuM.S., WuC.Y., ChenC.J., LinM.T., ShunC.T., LinJ.T.2003. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer, 104:617–623.
34.
XiaoH., JiangY., LiR., XiaB.2009. Association of IL-10 gene polymorphisms with gastroduodenal diseases in Hubei Han population. Chin J Med Genet, 26:423–426.
35.
XueH., LinB., NiP., XuH., HuangG.2010. Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol, 25:1604–1617.
36.
XueH., NiP., LinB., XuH., HuangG.2011. X-Ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: a HuGE review and meta-analysis. Am J Epidemiol, 173:363–375.
37.
YangL.2006. Incidence and mortality of gastric cancer in China. World J Gastroenterol, 12:17–20.
38.
ZambonC.F., BassoD., NavagliaF., BellucoC., FaldaA., FogarP., GrecoE., GalloN., RuggeM., Di MarioF., PlebaniM.2005. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine, 29:141–152.
39.
ZhouS.Z., ZhuW.L., LiM.Y., LiH.Y., ZhangJ.R.2008a. Association of single nucleotide polymorphism at interleukin-10 gene 1082 with the risk of gastric cancer in Chinese population. J South Med Univ, 28:1335–1338.
40.
ZhouY., HuW., ZhuangW., WuX.2011. Interleukin-10–1082 promoter polymorphism and gastric cancer risk in a Chinese Han population. Mol Cell Biochem, 347:89–93.
41.
ZhouY., LiN., ZhuangW., LiuG.J., WuT.X., YaoX., DuL., WeiM.L., WuX.T.2008b. Interleukin-10-1082 promoter polymorphism associated with gastric cancer among Asians. Eur J Cancer, 44:2648–254Review.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
